Post-Cataract Surgery Inflammation/
Corneal
Refractive Surgery
ASCRS Clinical Survey respondents report an
average of 5% of their cataract patients have
1+ cell/flare or greater 3–7 days after cataract
surgery. 28% report that 6% or more of their
patients experience 1+ cell/flare or greater 3–7
days after surgery.
Nearly a fifth of surgeons think it is somewhat
not or not important to combine both
corticosteroids and NSAIDs to treat
postoperative inflammation and control pain
following a routine cataract surgery case.
More than 30% of ASCRS respondents plan to
use intracameral antibiotic injections within the
next 12 months. 40% of physicians are currently
using intracameral antibiotic injections. Non-U.S.
respondents are nearly 75% more likely to use
these injections than U.S. respondents.
Respondents think that LASIK significantly
increases dry eye in an average of 30% of their
patients 3 months after surgery. This drops to
25% at 6 months postop.
ASCRS
2016 Clinical Survey
7
